UY28909A1 - Prodrogas de estradiol - Google Patents
Prodrogas de estradiolInfo
- Publication number
- UY28909A1 UY28909A1 UY28909A UY28909A UY28909A1 UY 28909 A1 UY28909 A1 UY 28909A1 UY 28909 A UY28909 A UY 28909A UY 28909 A UY28909 A UY 28909A UY 28909 A1 UY28909 A1 UY 28909A1
- Authority
- UY
- Uruguay
- Prior art keywords
- estradiol
- products
- estradiol products
- prodiges
- steroid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Prodrogas de estradiol de la fórmula general (I), donde el grupo Z está unido al esteroide, un procedimiento para su preparación, composiciones farmacéuticas que contienen estos compuestos y su uso para preparar medicamentos con efecto estrógeno.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004025966A DE102004025966A1 (de) | 2004-05-21 | 2004-05-21 | Estradiol-Prodrugs |
Publications (1)
Publication Number | Publication Date |
---|---|
UY28909A1 true UY28909A1 (es) | 2005-12-30 |
Family
ID=34969196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY28909A UY28909A1 (es) | 2004-05-21 | 2005-05-19 | Prodrogas de estradiol |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1747230A1 (es) |
JP (1) | JP2007538025A (es) |
AR (1) | AR050335A1 (es) |
DE (1) | DE102004025966A1 (es) |
GT (1) | GT200500121A (es) |
PA (1) | PA8633701A1 (es) |
PE (1) | PE20060359A1 (es) |
SV (1) | SV2006002121A (es) |
TW (1) | TW200613315A (es) |
UY (1) | UY28909A1 (es) |
WO (1) | WO2005113574A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10027887A1 (de) | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
US7534780B2 (en) | 2004-05-21 | 2009-05-19 | Bayer Schering Pharma Aktiengesellschaft | Estradiol prodrugs |
DE102004025985A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estriol- und Estetrol-Prodrugs |
DE102005057224A1 (de) * | 2005-11-29 | 2007-05-31 | Bayer Schering Pharma Ag | Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
DE102005057225A1 (de) * | 2005-11-29 | 2007-05-31 | Bayer Schering Pharma Ag | Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
DE102005057408A1 (de) * | 2005-11-30 | 2007-05-31 | Bayer Schering Pharma Ag | Sulfamoylsulfonat-Prodrugs |
AU2014287049B2 (en) * | 2013-07-11 | 2019-09-26 | Evestra, Inc. | Pro-drug forming compounds |
CN115368427B (zh) * | 2022-08-17 | 2024-02-13 | 南宁师范大学 | 雌二醇硒氰酸酯类化合物及其制备方法与应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1238739A (fr) * | 1958-08-04 | 1960-08-19 | Chimiotherapie Lab Franc | Procédé de préparation de dérivés hydrosolubles de testostérone |
FR8290M (es) * | 1968-12-31 | 1970-11-09 | Rech Chimiques Et Ind Mar Lab | |
US5001234A (en) * | 1987-04-16 | 1991-03-19 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
US5571933A (en) * | 1994-11-17 | 1996-11-05 | Duquesne University Of The Holy Ghost | Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use |
DE19712488A1 (de) * | 1997-03-25 | 1998-10-01 | Knoell Hans Forschung Ev | Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben |
JPWO2001081364A1 (ja) * | 2000-04-24 | 2004-01-08 | 協和醗酵工業株式会社 | エストラ−1,3,5(10)−トリエン誘導体 |
DE10027887A1 (de) * | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
GB0015876D0 (en) * | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
GB0316290D0 (en) * | 2003-07-11 | 2003-08-13 | Glaxo Group Ltd | Novel compounds |
TWI331154B (en) * | 2003-11-12 | 2010-10-01 | Solvay Pharm Gmbh | Novel 17-hydroxysteroid dehydrogenase type i inhibitors |
DE102004025985A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estriol- und Estetrol-Prodrugs |
-
2004
- 2004-05-21 DE DE102004025966A patent/DE102004025966A1/de not_active Withdrawn
-
2005
- 2005-05-10 JP JP2007517046A patent/JP2007538025A/ja active Pending
- 2005-05-10 EP EP05747458A patent/EP1747230A1/de not_active Withdrawn
- 2005-05-10 WO PCT/EP2005/005254 patent/WO2005113574A1/de active Application Filing
- 2005-05-19 UY UY28909A patent/UY28909A1/es not_active Application Discontinuation
- 2005-05-20 TW TW094116503A patent/TW200613315A/zh unknown
- 2005-05-20 PE PE2005000557A patent/PE20060359A1/es not_active Application Discontinuation
- 2005-05-20 AR ARP050102083A patent/AR050335A1/es unknown
- 2005-05-20 PA PA20058633701A patent/PA8633701A1/es unknown
- 2005-05-20 GT GT200500121A patent/GT200500121A/es unknown
- 2005-05-23 SV SV2005002121A patent/SV2006002121A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200613315A (en) | 2006-05-01 |
PE20060359A1 (es) | 2006-05-25 |
AR050335A1 (es) | 2006-10-18 |
WO2005113574A1 (de) | 2005-12-01 |
SV2006002121A (es) | 2006-02-15 |
JP2007538025A (ja) | 2007-12-27 |
PA8633701A1 (es) | 2006-07-03 |
EP1747230A1 (de) | 2007-01-31 |
GT200500121A (es) | 2006-01-30 |
DE102004025966A1 (de) | 2005-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY28909A1 (es) | Prodrogas de estradiol | |
AR027060A1 (es) | Bases de mannich de 1-naftol y 2-naftol sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos, asi como el uso deestos compuestos para la fabricacion de medicamentos | |
UY30824A1 (es) | Nuevos derivados de idazolil éster o amida, composiciones farmacéuticas conteniéndolas, procesos de preparacion y aplicaciones. | |
UY30711A1 (es) | Nuevos derivados de 1,4-benzotiepina-1, 1-cioxido, método para su preparacion, productos farmacéuticos que comprenden estos compuestos y su uso.- | |
BRPI0712631A8 (pt) | compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações | |
UY28910A1 (es) | Prodrogas de estriol y estetrol | |
ECSP066667A (es) | Derivados de ciclohexano espirociclicos | |
SV2002000249A (es) | Derivados de tiazolilamida ref, lea 34082-sv | |
AR025052A1 (es) | Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos. | |
CU23415B7 (es) | Derivados de 2,6- quinolinilo y 2,6- naftilo, procesos para su preparación y sus usos | |
UY28911A1 (es) | Profármacos de esteroides con acción androgénica | |
CU20110185A7 (es) | Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad glucocorticoide | |
UY30356A1 (es) | Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos. | |
CL2009001342A1 (es) | Pregn-4-en-21,17-carbolactonas sustituidas en el anillo c; preparados farmaceuticos que lo contienen; compuesto 11 alfa-hidroxi-15 beta, 16 beta-metilen-androst-4-en-3,17-diona; procedimiento para preparar dicho compuesto que comprende el uso de microorganismos. | |
UY27133A1 (es) | 11beta-halogenesteroides, su obtención y uso para la preparación de medicamentos y preparados farmacéuticos que contienen 11 beta-halogenesteroides | |
CR7672A (es) | Metodo microbiologico para la produccion de 11- alfa- hidroxiesteroides 7- alfa sustituidos | |
ECSP088481A (es) | Prodrogas de sustancias er-beta-selectivas, procesos para su preparación y composiciones farmacéuticas que comprenden estos productos | |
UY26507A1 (es) | Bases de mannich de 1-naftol y 2-naftol sustituidos, procedimiento para su preparación, medicamentos que contienen estos compuestos, así como el uso de estos compuestos para la preparación de medicamentos | |
UY28846A1 (es) | D-homo-17-cloro-16 (17) eno esteroides | |
ECSP066973A (es) | D-homo-17-cloro-16(17)eno esteroides | |
CL2009001370A1 (es) | Formas cristalinas de (r,s)-, (r)- y (s)-dopc; proceso de preparacion; composicion farmaceutica; y su uso para preparar medicamentos. | |
BRPI0518620A2 (pt) | compostos, composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço, e, uso de um composto | |
ECSP11011501A (es) | 17 -alquil-17 -oxi-estratrienos | |
ECSP088482A (es) | Prodrogas de sustancias er-beta-selectivas, procesos para su preparación, y composiciones farmacéuticas que contienen estos compuestos | |
CL2008000864A1 (es) | Compuestos derivados de pirimidina; composicion farmaceutica que comprende a dichos compuestos; procedimiento de preparacion de la composicion farmaceutica; y su uso para enfermedades relacionadas con el factor de crecimiento analogo a la insulina (igf). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20160518 |